Idamycin

Active Ingredient(s): Idarubicin
FDA Approved: * September 27, 1990
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Idamycin Overview

Idarubicin /adrubsn/ or 4-demethoxydaunorubicin is an anthracycline antileukemic drug. It inserts[1] itself into DNA and prevents DNA unwinding by interfering with the enzyme topoisomerase II. It is an analog of daunorubicin, but the absence of a methoxy group increases its fat solubility and cellular uptake.[2] Similar to other anthracyclines, it also induces histone eviction from chromatin.[3] It belongs to the family of drugs called antitumor...

Read more Idamycin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Idarubicin

Recent Idamycin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Idarubicin
  • Injection: 10mg/vial, 1mg/ml, 20mg/vial, 5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Idarubicin or a similar ingredient: (2 results)